Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic Model-Reference-Cited by-同舟云学术

Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic Model

Published:2019 Issue:7/8 Volume:42 Page:366-374
ISSN:2296-5270
Container-title:Oncology Research and Treatment
language:en
Short-container-title:Oncol Res Treat

Author:

Betschart Patrick,Babst Christa,Schmid Sabine,Rothermundt Christian,Abt Dominik,Schwab Christoph,Gillessen Silke,Engeler Daniel Stephan,Klingbiel Dirk,Schmid Hans-Peter,Omlin Aurelius

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology

Reference16 articles.

1. Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, et al. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. N Engl J Med. 2015 Aug;373(8):737–46.

2. James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, et al; STAMPEDE Investigators. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet. 2016 Mar;387(10024):1163–77.

3. Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, et al; LATITUDE Investigators. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. N Engl J Med. 2017 Jul;377(4):352–60.

4. James ND, de Bono JS, Spears MR, Clarke NW, Mason MD, Dearnaley DP, et al; STAMPEDE Investigators. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. N Engl J Med. 2017 Jul;377(4):338–51.

5. Strebel RT, Sulser T, Schmid HP, Gillessen S, Fehr M, Huber U, et al. Multidisciplinary care in patients with prostate cancer: room for improvement. Support Care Cancer. 2013 Aug;21(8):2327–33.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of uro-oncology multidisciplinary team meeting (MDTM) on clinical decision-making and adherence to MDTM recommendation: experience from a tertiary referral centre in Malaysia;African Journal of Urology;2024-03-11

2. Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer;Cancer Treatment Reviews;2024-01

3. Implementation of the measure of case discussion complexity to guide selection of prostate cancer patients for multidisciplinary team meetings;Cancer Medicine;2023-05-31

4. An approach to genetic testing in patients with metastatic castration-resistant prostate cancer in Singapore;Annals of the Academy of Medicine, Singapore;2023-03-30

5. Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients;Journal of Multidisciplinary Healthcare;2023-02